You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Lithuania

Mar 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

No consumer health rebound just yet

Consumer health turnover continued to decline in 2011, albeit at a slower rate than in the previous two years. The area continued to be subject to difficult conditions and to receive criticism from both consumers and politicians as a result of alleged excessive profits. Turnover continued to fall from the peak of 2007 and no growth drivers emerged during the review period. More importantly, companies engaged in often desperate heavy discounting in a bid to maintain turnover. Indeed, even those companies that initially refused to slash prices succumbed to the trend in 2011.

Sales stagnate as companies focus on lower income consumers

The fact that the expected rebound in sales did not occur in 2011 should come as no surprise to consumer health players, with product innovation being non-existent throughout the year. While the decision to focus on deep discounting was understandable, the failure to target the still-sizeable number of above-average income shoppers who are willing to pay extra for convenience will certainly backfire in the future, especially given the rise in the popularity of private label brands.

Rising demand for private label brands

As if the receding spending power of consumers was not enough, consumer health players also faced the challenge of rising demand for private label brands during 2011. Despite only being introduced a few years ago, private label products experienced strong demand in 2011. Commoditised dietary supplements was the first area to suffer from the launch of private label products and there is no reason to expect that retailers will not continue to launch more products over the coming years. The timing is perfect for private label brands since in addition to high consumer price sensitiveness, many popular brands have significantly reduced spending on advertising.

Chemists and pharmacies continue to dominate distribution

Chemists and pharmacies continued to lead distribution within consumer health in 2011. The proximity of stores, wide product ranges and, most importantly, cheap prices which are aggressively promoted via brochures and leaflets, continued to attract customers into chemists and pharmacies. However, despite giving out loyalty cards, consumers remain highly price motivated in this area and are willing to switch stores if needed.

Consumer health players facing new reality

There was a significant change in the outlook of consumer health players during 2011. While declining sales were initially only thought of as a temporary setback, companies are now becoming more pessimistic. This disillusionment can be attributed to a number of different reasons. For example, Lithuania’s population continues to decline due to both emigration and demographic trends while consumer disposable incomes are stagnating, especially amongst retirees, many of whom live of paltry sums. In addition, when also considering the rising popularity of private label products and self-inflicted brand erosion, the goal of catching-up with Western European consumption levels, which seemed realistic only a few years ago, no longer appears achievable.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Lithuania with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Lithuania, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Lithuania for free:

The Consumer Health in Lithuania market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Lithuania?
  • What are the major brands in Lithuania?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Lithuania - Industry Overview

EXECUTIVE SUMMARY

No consumer health rebound just yet

Sales stagnate as companies focus on lower income consumers

Rising demand for private label brands

Chemists and pharmacies continue to dominate distribution

Consumer health players facing new reality

KEY TRENDS AND DEVELOPMENTS

Discounting remains dominant sales tactic

Private label brands threaten branded goods

Vitamins and dietary supplements attracting companies

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Penetration of Private Label by Category 2006-2011
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication and self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2009-2011

DEFINITIONS

  • Summary 2 Research Sources

Consumer Health in Lithuania - Company Profiles

Sanitas AB in Consumer Health (Lithuania)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 5 Sanitas AB: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 6 Sanitas AB: Competitive Position 2011

Sicor Biotech UAB in Consumer Health (Lithuania)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Valentis UAB in Consumer Health (Lithuania)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 11 Valentis UAB: Competitive Position 2011

Adult Mouth Care in Lithuania - Category Analysis

HEADLINES

TRENDS

  • Despite personal finance difficulties, consumers did not reduce expenditure on adult mouth care products in 2011. The area, although not a large one in terms of absolute turnover, continued to benefit from rising hygiene standards in Lithuania.

SWITCHES

COMPETITIVE LANDSCAPE

  • Although adult mouth care is relatively small in absolute terms, this does not stop many companies from competing within it. Multinationals with good product availability, strong brands and affordable prices managed to secure some sales share in 2011. Pfizer and Pierre Fabre led sales within the area due to the popularity of their respective Hexoral and Eludril brands, which recorded a combined retail value share of 55%.

PROSPECTS

  • Sales of adult mouth care products are expected to rebound gradually in line with the general economic recovery. The increasing hygiene standards of Lithuanians, as well as endorsements from mouth specialists, will drive growth within the area over the coming years.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2006-2011
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 14 Adult Mouth Care Company Shares 2007-2011
  • Table 15 Adult Mouth Care Brand Shares 2008-2011
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Lithuania - Category Analysis

HEADLINES

TRENDS

  • Analgesics sales continued to fall during 2011, albeit at a slower rate than in the previous two years. Consumer price sensitivity, especially amongst older people who account for the majority of sales, resulted in a decline in sales, with many shoppers only being prepared to pay the prices offered during price-slashing campaigns. Overall, due to a lack of innovation regarding new delivery formats or other product attributes, firms competed on price – a development which eroded value sales.

SWITCHES

COMPETITIVE LANDSCAPE

  • Nycomed SEFA finally became the leading player within analgesics in 2011, recording a retail value share of 18% - a one percentage point rise from 2010. The company’s Ibumetin was the best-selling brand within analgesics, with demand being fuelled by both relatively low prices, frequent promotions within pharmacy leaflets and the offering of discounts.

PROSPECTS

  • The increasing number of elderly people developing age-related illnesses accompanied by muscle, joint or head pain ensures that demand for analgesics will remain sound over the forecast period. Also, health specialists warn that many younger people will also be forced to seek such remedies as a result of their lifestyle choices. Since these problems are usually solved via self-medication, the use of analgesics will not decline any time soon.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2006-2011
  • Table 19 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 20 Analgesics Company Shares 2007-2011
  • Table 21 Analgesics Brand Shares 2008-2011
  • Table 22 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Lithuania - Category Analysis

HEADLINES

TRENDS

  • The low spending power of elderly consumers, who account for the majority of demand, had a negative impact on calming and sleeping sales in 2011. Many older people depend on meagre state pensions and in response to higher food and housing costs were forced to trim spending on medicines. This usually resulted in trading down to cheaper products, something which was easy to do considering the extensive price discounting within the area.

SWITCHES

COMPETITIVE LANDSCAPE

  • Valentis, a local producer, continued to lead sales in 2011, recording a retail value share of 23%. The firm has been operating in the area for many years and knows the domestic market well. Moreover, Valentis promotes its products frequently by slashing prices, something which consumers highly appreciate. However, the firm is vulnerable to on-going consumer price sensitivity, with demand for its leading Rameval brand suffering from its high price.

PROSPECTS

  • Recent changes in society, such as the rising number of old consumers and the increase in the number of younger people suffering from work-related anxiety and stress, present plenty of opportunities for growth within calming and sleeping. Moreover, Lithuanians are much less educated about various non-harmful products that could help or at least relieve their sleeping problems.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2006-2011
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 26 Calming and Sleeping Company Shares 2007-2011
  • Table 27 Calming and Sleeping Brand Shares 2008-2011
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Lithuania - Category Analysis

HEADLINES

TRENDS

  • The expected recovery of cough, cold and allergy (hay fever) sales did not occur in 2011. Consumers were unwilling to part with their money and prices were further pressed by intensifying competition and heavy discounting. Moreover, mild climate conditions resulted in the limited incidence of flu in 2011. Without the normal annual flu epidemic, demand for cough, cold and allergy (hay fever) medicine was lower than in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • With a vast number of brands offered at a discounted price, competition within the area is almost exclusively based on price. However, producers which successfully built strong brands before the economic downturn continue to lead sales. Gripex from US Pharmacia led sales in 2011 with a retail value share of 8%. The brand is well-known amongst all potential consumers, receives moderate marketing support and has proven its efficacy to consumers plagued by flu-like symptoms.

PROSPECTS

  • Cough, cold and allergy (hay fever) sales depend heavily on weather conditions as demand for remedies cannot be created artificially like in other areas such as dietary supplements, where brands claim to strengthen the immune system. Cough, cold and allergy (hay fever) sales will increase only slightly in future years. With the exception of epidemic or pandemic driven panics, like in 2010, demand will remain relatively stable and producers will continue to experience pressure to minimise prices.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2007-2011
  • Table 33 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2008-2011
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 35 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Lithuania - Category Analysis

HEADLINES

TRENDS

  • The prolonged economic downturn appears to have had little impact on the dietary habits of Lithuanians. Whilst the area did record a slight decline in sales, this was only due to continuing pressure to lower prices, with demand remaining as robust as ever in volume terms.

SWITCHES

COMPETITIVE LANDSCAPE

  • A Menarini Industrie Farmaceutiche Riunite continued to dominate sales in 2011, recording a retail value share of 58%. The company’s dominance can be attributed to the strong performance of its Mezym and Raniberl brands, which recorded respective retail value shares of 34% and 16%. The brands enjoy a high level of trust amongst consumers due to the fact that they have been available for many years. Even more importantly, the fact that the company behind these brands invested strongly in advertising before the recent recession means that its brands are particularly well-known. This is especially true for Mezym, which is the best-known brand in Lithuania. On the other hand, the company’s Espumisan brand is losing sales share – a fact that suggests that advertising only drives sales for a certain period of time, after which sales decline.

PROSPECTS

  • The ageing of the Lithuanian population and the growing number of people leading sedentary lifestyles and not eating properly will help to fuel demand for digestive remedies in the future. If the past is any guide, there is also scope for additional gains via media advertising. However, growth rates will not reach those observed during the earlier years of the review period. More rational spending habits and improved education on digestive remedies will only lead to purchases when and if they are necessary. Despite being widely available, products within the area will mostly be purchased following a recommendation from a personal health specialist.

CATEGORY DATA

  • Table 36 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 37 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 38 Digestive Remedies Company Shares 2007-2011
  • Table 39 Digestive Remedies Brand Shares 2008-2011
  • Table 40 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 41 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Lithuania - Category Analysis

HEADLINES

TRENDS

  • The frugal habits of consumers had a negative impact on the performance of ear care products in Lithuania in 2011. Despite stable demand, price sensitive consumers waited patiently for discounts before purchasing. The consumption of ear care products became much more rational, with many consumers only purchasing such products when it was absolutely necessary.

SWITCHES

COMPETITIVE LANDSCAPE

  • Biocodex Laboratoires led ear care sales in 2011, recording a retail value share of 48% due to the popularity of its Otipax brand. ICN Pharmaceutical ranked second, with its Otinum brand recording a retail value share of 37%. These two brands have been available for long enough to build up strong trust amongst consumers and are also widely recommended by physicians.

PROSPECTS

  • Only modest growth is predicted within ear care over the coming years. The area is significantly less promising than others as demand cannot be increased using traditional marketing strategies. As a result, any company entering the area will have to engage in a price war with incumbent players to attract consumers – something which most players are unprepared to do.

CATEGORY DATA

  • Table 42 Sales of Ear Care: Value 2006-2011
  • Table 43 Sales of Ear Care: % Value Growth 2006-2011
  • Table 44 Ear Care Company Shares 2007-2011
  • Table 45 Ear Care Brand Shares 2008-2011
  • Table 46 Forecast Sales of Ear Care: Value 2011-2016
  • Table 47 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Lithuania - Category Analysis

HEADLINES

TRENDS

  • The decision to switch emergency contraception products from RX to OTC has had only a limited impact on the fortunes of retailers and producers of such products in Lithuania. Although sizeable budgets were assigned for emergency contraception products following the switch in 2009, the global credit crunch and the collapse of the overheated economy prevented the area from achieving its potential. In 2011, spending on product promotion fell as priorities shifted towards larger areas – a development which obviously had a negative impact on sales.

COMPETITIVE LANDSCAPE

  • A lack of competition within emergency contraception is partly to blame for the so-so results in the area in recent years. Richter Gedeon Nyrt completely dominates sales, owning the two equally priced brands available, Escapelle and Postinor-2 - both of which are available in pharmacies. Escapelle generated nearly twice as many sales as Postinor-2 in 2011. The former has only one pill in its package while the later has two, making it somewhat more difficult to use. Faced with identical prices, Lithuanian shoppers usually chose Escapelle.

PROSPECTS

  • The performance of emergency contraception will largely depend on the level of competition within the area and, to a lesser extent, the awareness of such products amongst targeted consumers. As long as Richter Gedeon Nyrt has a monopoly, any major changes, such as a decline in prices or larger advertising budgets are unlikely. However, the arrival of a new player would shake the area and have a positive impact on its development.

CATEGORY DATA

  • Table 48 Sales of Emergency Contraception: Value 2009-2011
  • Table 49 Sales of Emergency Contraception: % Value Growth 2009-2011
  • Table 50 Emergency Contraception Company Shares 2007-2011
  • Table 51 Emergency Contraception Brand Shares 2008-2011
  • Table 52 Forecast Sales of Emergency Contraception: Value 2011-2016
  • Table 53 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Eye Care in Lithuania - Category Analysis

HEADLINES

TRENDS

  • The fact that eye care products are perceived as being essential helped to minimise the decline in sales within the area in 2011. As a result of Lithuania’s ageing population and the fact that a large number of professionals spend their days starring at computer screens, there is plenty of scope for further growth within eye care over the coming years. However, limited consumer spending power and the fact that the majority of older Lithuanians are poor is having a negative impact on demand, with sales falling slightly in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • Alcon-Couvreur led sales within the fragmented eye care area in 2011 due to the popularity of its Tears Naturale and Systane brands, with the company recording combined retail value sales of nearly LTL1 million. However, the company was closely followed by Santen Pharmaceutical (Oftagel, the country’s best selling eye car brand, Lecrolyn) and Unimed Pharma (Hypromeloza P, Sensivit) , each of which recorded a retail value share of 19%.

PROSPECTS

  • The increasing number of elderly people with eye health problems and the proliferation of computer, I-phone and tablet usage mean that eye care is well positioned for future growth.

CATEGORY DATA

  • Table 54 Sales of Eye Care by Category: Value 2006-2011
  • Table 55 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 56 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 57 Standard Eye Care by Positioning 2007-2011
  • Table 58 Eye Care Company Shares 2007-2011
  • Table 59 Eye Care Brand Shares 2008-2011
  • Table 60 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 61 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Lithuania - Category Analysis

HEADLINES

TRENDS

  • Consumers continued to seek herbal and traditional products in 2011 in line with the general trend towards consumption of more natural and organic goods. However, while the purchasing of herbal and traditional medicine was considered trendy a few years ago, consumers are now much more rational when making decisions. As a result, herbal and traditional brands are only purchased when they are priced comparably to standard medicines.

COMPETITIVE LANDSCAPE

  • Acorus Calamus continued to lead sales in 2011, recording a retail value share of 10% and sales of LTL6 million. The firm offers a range of various teas and benefited greatly from rising consumer interest in such products. The company’s products were available not only in pharmacies, which traditionally account for the majority of sales, but also in traditional grocery stores, where constant footfall ensures additional revenue.

PROSPECTS

  • Despite declining sales in 2011, the trend towards healthier herbal and traditional products is expected to remain strong over the forecast period. Consumers will continue to seek natural products and at the same time will demand that the remedies are priced similarly to and as effective as standard goods.

CATEGORY DATA

  • Table 62 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 63 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 64 Herbal/Traditional Products Company Shares 2007-2011
  • Table 65 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 66 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 67 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Lithuania - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care showed signs of stabilising in 2011. Current retail value sales fell by just 1% in 2011, mainly due to the fact that products within the area are necessary for consumers who have little hesitation about spending on medicines recommended by a dermatologist.

SWITCHES

COMPETITIVE LANDSCAPE

  • Due to the high number of available brands, each of which address different problems, medicated skin care remains fragmented, with each area having its own leaders. Novartis continued to lead sales in 2011, recording a retail value share of 8% - a slight increase from 2010. Novartis’ success can be attributed to the popularity of its Hepagel and Lamisil brands, both of which are often recommended by physicians.

PROSPECTS

  • Consumption levels within medicated skin care are not expected to return to those seen pre-crisis, when various products in this area were used for precautionary measures or even when completely unnecessary. However, slowly improving household incomes are expected to affect sales positively. Rising consumer awareness of abnormal skin conditions will help to boost sales within this area over the coming years.

CATEGORY DATA

  • Table 68 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 69 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 70 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 71 Medicated Skin Care Brand Shares 2008-2011
  • Table 72 Hair Loss Treatments Brand Shares 2008-2011
  • Table 73 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 74 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Lithuania - Category Analysis

HEADLINES

TRENDS

  • NRT smoking cessation aids did not have a good year in 2011 due to sparse advertising, with awareness of the availability of products within the area remaining very limited. The price of tobacco products increased in 2011 due to rising excise duties. Despite rising sales of smuggled tobacco products, the overall number of smokers in Lithuania fell from 701,000 to 636,000 in 2011. However, only a small fraction of people looking to quit smoking used NRT smoking cessation aids, with the majority relying on abstention and willpower.

SWITCHES

COMPETITIVE LANDSCAPE

  • The fact that only two companies are active within NRT smoking cessation aids in Lithuania helps to explain the sluggish performance of the area over the review period. The fact that smoking cessation has little potential to become a major area in Lithuania means that it is dominated by multinationals with numerous interests in other consumer healthcare areas.

PROSPECTS

  • Although the number of smokers is expected to fall in the near future, NRT smoking cessation aids will probably contribute little to this decline. Weak spending power, doubts about the efficacy of products and a lack of promotion means that purchases of NRT smoking cessation aids will remain limited. Disappointing previous results will also curb the enthusiasm of companies to enter the area once the economic climate improves due to more lucrative opportunities elsewhere.

CATEGORY INDICATORS

  • Table 75 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 76 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 77 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 78 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 79 NRT Smoking Cessation Aids Company Shares 2007-2011
  • Table 80 NRT Smoking Cessation Aids Brand Shares 2008-2011
  • Table 81 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 82 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Lithuania - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition sales remained relatively stable in 2011, declining only slightly in comparison to 2010. This was because only hard-core users, mostly professional athletes, are still using such products as most previous occasional users abandoned the area over the last few years. Despite the increasing availability of sports nutrition products (some products are already available in supermarkets and hypermarkets), sales remain limited as consumers lack both interest in and knowledge of such products.

COMPETITIVE LANDSCAPE

  • Universal Nutrition continued to lead sales in 2011, recording a retail value share of 17% - a two percentage point increase from 2010. Universal is the best know brand in Lithuania in this area due to the fact that the company entered sports nutrition very early and became well known because of sponsorship deals with fitness competitions and promotional activities within gyms.

PROSPECTS

  • Sports nutrition will remain a niche consumer health area in the immediate future. Only professional athletes and teenagers desperate to gain a few pounds of muscle consider sports nutrition products as being vital, while for the rest they remains something that can be given up. Only when the economy rebounds and potential consumers feel safe about their financial prospects will sports nutrition retailers expect to record significantly higher sales.

CATEGORY DATA

  • Table 83 Sales of Sports Nutrition: Value 2006-2011
  • Table 84 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 85 Sports Nutrition Company Shares 2007-2011
  • Table 86 Sports Nutrition Brand Shares 2008-2011
  • Table 87 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 88 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Lithuania - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements is not as strictly regulated as other OTC areas. For instance, there are no upper or lower limits on profit margins. However, the area appears to be even more in need of attention as a result of the behaviour of both consumers and companies in the past few years. Consumers are increasingly demanding cheaper pills, which retailers can only offer by lowering their own margins or squeezing their suppliers. However, consumers were not impressed and continue to seek the cheapest possible products.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Domestic companies continued to lead the fragmented vitamins and dietary supplements area in 2011. Aconitum and Biosola led sales, recording respective retail value shares of 9% and 6%. Both of these companies have a strong presence, with their brands being available in all major vitamins and dietary supplements retailers. Moreover, these firms are also the most aggressive when it comes to price-slashing. Although competitors suggested that such tactics would backfire and possibly even end up in the bankruptcy of leading players, such fears proved to be unfounded.

PROSPECTS

  • The difficulties being experienced by Lithuania’s economy as well as weak spending power do not bode well for vitamins and dietary supplements. Although many consumers mistake supplements for medicines, such purchases are only made after all other monthly expenditure (eg food and housing) has been made. On the other hand, Lithuanians are increasingly concerned about their poor nutritional habits which, coupled with constant media scares about the quality of food in grocery stores, often helps to boost demand for vitamins and dietary supplements.

CATEGORY DATA

  • Summary 12 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 89 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 90 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 91 Dietary Supplements by Positioning 2007-2011
  • Table 92 Vitamins and Dietary Supplements Company Shares 2007-2011
  • Table 93 Vitamins and Dietary Supplements Brand Shares 2008-2011
  • Table 94 Vitamins Brand Shares 2008-2011
  • Table 95 Dietary Supplements Brand Shares 2008-2011
  • Table 96 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 97 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Lithuania - Category Analysis

HEADLINES

TRENDS

  • Weight management products continue to be adversely affected by low consumer spending power. Despite the large number of consumers, primarily women, concerned about their appearance, weight management products were left out of the shopping lists of many Lithuanians. Players within the area are also partly to blame as they failed to generate as much buzz as they did in previous years.

COMPETITIVE LANDSCAPE

  • Vitamins For Life and New Nordic Healthcare ApS lead all players in weight management, each accounting for 16% of total value sales. These firms have been competing within the area for many years and products such as Appetite STOP and apple cider are familiar to consumers who regularly purchase weight management products.

PROSPECTS

  • Lithuanians are expected to continue paying a lot of attention to their looks, especially women, who account for the majority of weight management sales. Pressure from the media will mean that a growing number of people will be dissatisfied with their appearance while sedentary lifestyles and poor nutritional habits will make matters even worse. However, for sales to pick-up, there will first have to be an improvement in the economy – a development which is currently far from certain.

CATEGORY DATA

  • Table 98 Sales of Weight Management by Category: Value 2006-2011
  • Table 99 Sales of Weight Management by Category: % Value Growth 2006-2011
  • Table 100 Weight Management Company Shares 2007-2011
  • Table 101 Weight Management Brand Shares 2008-2011
  • Table 102 Forecast Sales of Weight Management by Category: Value 2011-2016
  • Table 103 Forecast Sales of Weight Management by Category: % Value Growth 2011-2016

Wound Care in Lithuania - Category Analysis

HEADLINES

TRENDS

  • Consumers avoided unnecessary spending on all consumer health goods in 2011, with wound care products proving no exception. Although wound care products are vital in the event of a major accident, Lithuanians, still feeling the pain of economic recession, opted for cheaper goods every time they had a chance to do so. The fact that all wound care products are perceived as being similar discourages the purchasing of pricier options. On the other hand, the fact that wound care products have no substitutes means that yearly turnover is more stable compared with other consumer health areas.

COMPETITIVE LANDSCAPE

  • Laboratoires URGO led sales in 2011, recording a retail value share of 35%. The company’s Urgo brand is well known in Lithuania and, more importantly, available in all pharmacies as well as drugstores throughout the country. This universal availability and favourable shelf positioning is what makes the brand stand out from competitors.

PROSPECTS

  • The future of wound care will depend on the general development of the country’s economy. Only in a more optimistic economic climate can consumers be persuaded to try out new products such as sprayable plasters. Without such products, it will be very difficult to stimulate growth.

CATEGORY DATA

  • Table 104 Sales of Wound Care by Category: Value 2006-2011
  • Table 105 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 106 Wound Care Company Shares 2007-2011
  • Table 107 Wound Care Brand Shares 2008-2011
  • Table 108 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 109 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Paediatric Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Paediatric Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Paediatric Consumer Health
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
          • Paediatric Cough, Cold and Allergy Remedies
            • Paediatric Allergy Remedies
            • Paediatric Cough/Cold Remedies
          • Paediatric Digestive Remedies
            • Paediatric Diarrhoeal Remedies
            • Paediatric Indigestion and Heartburn Remedies
            • Paediatric Laxatives
            • Paediatric Motion Sickness Remedies
          • Paediatric Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Paediatric Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!